Protein synthesis inhibitor: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 23: | Line 23: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Ribosome_mRNA_translation_en.svg|Ribosome mRNA translation | |||
File:Protein_translation.gif|Protein translation | |||
</gallery> | |||
Latest revision as of 00:47, 18 February 2025
Protein synthesis inhibitors are substances that stop or slow the growth or proliferation of cells by disrupting the processes that lead directly to the generation of new proteins.
Mechanism of action[edit]
Protein synthesis inhibitors work at different stages of the process of protein synthesis. Some act to inhibit the synthesis of nucleic acids by interacting with the DNA and RNA found within the cell. Others inhibit the process of translation, which is the process that generates new proteins in the cell.
Types of protein synthesis inhibitors[edit]
There are several types of protein synthesis inhibitors, including aminoglycosides, tetracyclines, and macrolides. These are all types of antibiotics that work by inhibiting protein synthesis in bacteria, thus preventing them from growing and multiplying.
Clinical uses[edit]
Protein synthesis inhibitors are used in the treatment of a variety of bacterial infections. They are also used in research to study the process of protein synthesis.
Side effects[edit]
Like all medications, protein synthesis inhibitors can have side effects. These can include nausea, vomiting, diarrhea, and allergic reactions. In rare cases, they can also cause damage to the kidneys or ears.


